Display Settings:

Format

Send to:

Choose Destination
    Nutr Rev. 2004 Jan;62(1):28-32.

    High-dose antioxidant supplementation and cataract risk.

    Source

    Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison, Wisconsin 53705-2397, USA.

    Abstract

    In a recent clinical trial, supplementation with high-dose antioxidants lowered the progression of lens opacities. These results differ from those of several other larger trials, in which no benefit to high-dose antioxidant supplementation was observed. Although a large body of observational evidence suggests that supplement use is associated with lower risk for cataract, there is insufficient evidence that high-dose antioxidants slow the progression of cataracts beyond that provided by multivitamins or healthful diets.

    PMID:
    14995054
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Blackwell Publishing

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk